Abstract
Helicobacter pylori is a worldwide infection that causes chronic gastritis, duodenal ulcers, and malignancy. Transmission of Helicobacter pylori within a family appears to be the predominant mode of contamination. Recurrence of the infection is frequently seen following treatment. Lack of eradication due to either inadequate treatment or resistant bacteria vs. reinfection have been explanations for detection of H. pylori following treatment. In this article we will discuss the concepts of inadequate treatment vs. resistant infection and reinfection as causes of persistent H. pylori infection.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Go MF. Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther. 2002;16 Suppl 1:3–15. Epub 2002/02/19.
Goh KL, Chan WK, Shiota S, Yamaoka Y. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter. 2011;16 Suppl 1:1–9. Epub 2011/09/16.
Kivi M, Tindberg Y. Helicobacter pylori occurrence and transmission: a family affair? Scand J Infect Dis. 2006;38(6–7):407–17. Epub 2006/06/27.
Perry S, de la Luz Sanchez M, Yang S, Haggerty TD, Hurst P, Perez-Perez G, et al. Gastroenteritis and transmission of Helicobacter pylori infection in households. Emerg Infect Dis. 2006;12(11):1701–8. Epub 2007/02/08.
Axon AT. Review article: is Helicobacter pylori transmitted by the gastro-oral route? Aliment Pharmacol Ther. 1995;9(6):585–8.
Rowland M, Daly L, Vaughan M, Higgins A, Bourke B, Drumm B. Age-specific incidence of Helicobacter pylori. Gastroenterology. 2006;130(1):65–72. quiz 211. Epub 2006/01/13.
Malaty HM, El-Kasabany A, Graham DY, Miller CC, Reddy SG, Srinivasan SR, et al. Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet. 2002;359(9310):931–5.
Tuzun Y, Keskin S, Kote E. The role of Helicobacter pylori infection in skin diseases: facts and controversies. Clin Dermatol. 2010;28(5):478–82.
Mourad-Baars P, Hussey S, Jones NL. Helicobacter pylori infection and childhood. Helicobacter. 2010;15 Suppl 1:53–9. Epub 2010/11/26.
Pacifico L, Anania C, Osborn JF, Ferraro F, Chiesa C. Consequences of Helicobacter pylori infection in children. World J Gastroenterol. 2010;16(41):5181–94.
Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: A review. Gastroenterology. 1996;110(4):1244–52.
Fischbach W, Goebeler-Kolve ME, Dragosics B, Greiner A, Stolte M. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut. 2004;53(1):34–7.
Wotherspoon AC, Doglioni C, Diss TC, Pan LX, Moschini A, Deboni M, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid-tissue type after eradication of Helicobacter-pylori. Lancet. 1993;342(8871):575–7.
Azevedo NF, Guimaraes N, Figueiredo C, Keevil CW, Vieira MJ. A new model for the transmission of Helicobacter pylori: role of environmental reservoirs as gene pools to increase strain diversity. Crit Rev Microbiol. 2007;33(3):157–69.
Weyermann M, Rothenbacher D, Brenner H. Acquisition of Helicobacter pylori infection in early childhood: independent contributions of infected mothers, fathers, and siblings. Am J Gastroenterol. 2009;104(1):182–9.
Roma E, Panayiotou J, Pachoula J, Kafritsa Y, Constantinidou C, Mentis A, et al. Intrafamilial spread of Helicobacter pylori infection in Greece. J Clin Gastroenterol. 2009;43(8):711–5.
Sari YS, Can D, Tunali V, Sahin O, Koc O, Bender O. H pylori: treatment for the patient only or the whole family? World J Gastroenterol. 2008;14(8):1244–7.
• Azevedo N. The epidemiology of Helicobacter pylori and public health implications (vol 14, pg 1, 2009). Helicobacter. 2010;15(1):78. This review analyzed the epidemiology of H. pylori in different countries and reviews the mode of transmission of the infection and risk factors implicated.
Nahar S, Kibria KMK, Hossain ME, Sultana J, Sarker SA, Engstrand L, et al. Evidence of intra-familial transmission of Helicobacter pylori by PCR-based RAPD fingerprinting in Bangladesh. Eur J Clin Microbiol. 2009;28(7):767–73.
Konno M, Yokota S, Suga T, Takahashi M, Sato K, Fujii N. Predominance of mother-to-child transmission of Helicobacter pylori infection detected by random amplified polymorphic DNA fingerprinting analysis in Japanese families. Pediatr Infect Dis J. 2008;27(11):999–1003.
Cervantes DT, Fischbach LA, Goodman KJ, Phillips CV, Chen SD, Broussard CS. Exposure to Helicobacter pylori-positive siblings and persistence of Helicobacter pylori infection in early childhood. J Pediatr Gastr Nutr. 2010;50(5):481–5.
Goodman KJ, O’Rourke K, Day RS, Redlinger T, Sanchez J, Wang C, et al. Establishment of a binational cohort to study Helicobacter pylori infection in children. Ethn Dis. 2003;13(3):387–94. Epub 2003/08/05.
Moya DA, Crissinger KD. Helicobacter Pylori infection in household contacts of helicobacter pylori-infected children. J Pediatr Gastroenterol Nutr [Internet]. 2010;51 Suppl 2:E40.
Niv Y. H pylori recurrence after successful eradication. World J Gastroenterol. 2008;14(10):1477–8. Epub 2008/03/12.
Niv Y, Hazazi R. Helicobacter pylori recurrence in developed and developing countries: meta-analysis of 13C-urea breath test follow-up after eradication. Helicobacter. 2008;13(1):56–61. Epub 2008/01/22.
Gisbert JP. The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review. Am J Gastroenterol. 2005;100(9):2083–99. Epub 2005/09/01.
Leal-Herrera Y, Torres J, Monath TP, Ramos I, Gomez A, Madrazo-de la Garza A, et al. High rates of recurrence and of transient reinfections of Helicobacter pylori in a population with high prevalence of infection. Am J Gastroenterol. 2003;98(11):2395–402. Epub 2003/11/26.
Soto G, Bautista CT, Roth DE, Gilman RH, Velapatino B, Ogura M, et al. Helicobacter pylori reinfection is common in Peruvian adults after antibiotic eradication therapy. J Infect Dis. 2003;188(9):1263–75. Epub 2003/11/01.
Hildebrand P, Bardhan P, Rossi L, Parvin S, Rahman A, Arefin MS, et al. Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults. Gastroenterology. 2001;121(4):792–8. Epub 2001/10/19.
Kim N, Lim SH, Lee KH, Jung HC, Song IS, Kim CY. Helicobacter pylori reinfection rate and duodenal ulcer recurrence in Korea. J Clin Gastroenterol. 1998;27(4):321–6. Epub 1998/12/17.
Xia HX, Talley NJ, Keane CT, O’Morain CA. Recurrence of Helicobacter pylori infection after successful eradication: nature and possible causes. Dig Dis Sci. 1997;42(9):1821–34. Epub 1997/10/23.
Peitz U, Hackelsberger A, Malfertheiner P. A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy. Drugs. 1999;57(6):905–20. Epub 1999/07/10.
Kindermann A, Lopes AI. Helicobacter pylori infection in pediatrics. Helicobacter. 2009;14 Suppl 1:52–7. Epub 2009/08/29.
Zhang YY, Xia HH, Zhuang ZH, Zhong J. Review article: ‘true’ re-infection of Helicobacter pylori after successful eradication–worldwide annual rates, risk factors and clinical implications. Aliment Pharmacol Ther. 2009;29(2):145–60. Epub 2008/10/24.
Farrell S, Milliken I, Doherty GM, Murphy JL, Wootton SA, McCallion WA. Total family unit Helicobacter pylori eradication and pediatric re-infection rates. Helicobacter. 2004;9(4):285–8. Epub 2004/07/24.
Halitim F, Vincent P, Michaud L, Kalach N, Guimber D, Boman F, et al. High rate of Helicobacter pylori reinfection in children and adolescents. Helicobacter. 2006;11(3):168–72. Epub 2006/05/11.
Kato S, Abukawa D, Furuyama N, Iinuma K. Helicobacter pylori reinfection rates in children after eradication therapy. J Pediatr Gastroenterol Nutr. 1998;27(5):543–6. Epub 1998/11/20.
Xia HX, Windle HJ, Marshall DG, Smyth CJ, Keane CT, O’Morain CA. Recrudescence of Helicobacter pylori after apparently successful eradication: novel application of randomly amplified polymorphic DNA fingerprinting. Gut. 1995;37(1):30–4. Epub 1995/07/01.
Bani-Hani KE, Shatnawi NJ, El Qaderi S, Khader YS, Bani-Hani BK. Prevalence and risk factors of Helicobacter pylori infection in healthy schoolchildren. Chin J Dig Dis. 2006;7(1):55–60. Epub 2006/01/18.
Rowland M, Kumar D, Daly L, O’Connor P, Vaughan D, Drumm B. Low rates of Helicobacter pylori reinfection in children. Gastroenterology. 1999;117(2):336–41. Epub 1999/07/27.
•• Guarner J, Kalach N, Elitsur Y, Koletzko S. Helicobacter pylori diagnostic tests in children: review of the literature from 1999 to 2009. Eur J Pediatr. 2010;169(1):15–25. Epub 2009/07/21. This study compiles an extensive review of the literature that summarizes the sensitivity and specificity of invasive and non-invasive tests for H. pylori used in children.
McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med. 2010;362(17):1597–604. Epub 2010/04/30.
Kuipers EJ, Uyterlinde AM, Pena AS, Hazenberg HJ, Bloemena E, Lindeman J, et al. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am J Gastroenterol. 1995;90(9):1401–6. Epub 1995/09/01.
Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA. 2002;288(22):2880–3. Epub 2002/12/11.
•• Khurana R, Fischbach L, Chiba N, Van Zanten SV, Sherman PM, George BA, et al. Meta-analysis: Helicobacter pylori eradication treatment efficacy in children. Aliment Pharmacol Ther. 2007;25(5):523–36. Epub 2007/02/20. This study analyzed the efficacy of treatment and different factors involved when treating children for H. pylori. This report is important as few studies have been reported in children.
Oderda G, Dell’Olio D, Morra I, Ansaldi N. Campylobacter pylori gastritis: long term results of treatment with amoxycillin. Arch Dis Child. 1989;64(3):326–9. Epub 1989/03/01.
Campo SM, Zullo A, Hassan C, Morini S. Antibiotic treatment strategies for Helicobacter pylori infection. Recent patents on anti-infective drug discovery. 2007;2(1):11-7. Epub 2008/01/29
•• Koletzko S, Jones NL, Goodman KJ, Gold B, Rowland M, Cadranel S, et al. Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr. 2011;53(2):230–43. Epub 2011/05/12. This paper is an update on the clinical guidelines involving diagnostic and therapeutic approaches guided by a evidence-based medicine approach in pediatrics.
Gold BD, Colletti RB, Abbott M, Czinn SJ, Elitsur Y, Hassall E, et al. Helicobacter pylori infection in children: recommendations for diagnosis and treatment. J Pediatr Gastroenterol Nutr. 2000;31(5):490–7. Epub 2001/01/06.
Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut. 2010;59(8):1143–53. Epub 2010/06/08.
Malfertheiner P, Megraud F, O’Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007;56(6):772–81. Epub 2006/12/16.
Zullo A, De Francesco V, Hassan C, Morini S, Vaira D. The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis. Gut. 2007;56(10):1353–7. Epub 2007/06/15.
Koletzko S, Richy F, Bontems P, Crone J, Kalach N, Monteiro ML, et al. Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe. Gut. 2006;55(12):1711–6.
Gisbert JP, Morena F. Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure. Aliment Pharmacol Ther. 2006;23(1):35–44. Epub 2006/01/06.
Disclosure
No potential conflicts of interest is relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moya, D.A., Crissinger, K.D. Helicobacter Pylori Persistence in Children: Distinguishing Inadequate Treatment, Resistant Organisms, and Reinfection. Curr Gastroenterol Rep 14, 236–242 (2012). https://doi.org/10.1007/s11894-012-0251-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11894-012-0251-y